Isoflurane Sedation on the ICU in Cardiac Arrest Patients Treated with Targeted Temperature Management: An Observational Propensity-Matched Study

Critical Care Medicine

Volumn 45, Issue 4, 2017, Pages e384-e390

  Krannich, Alexander ^a   Leithner, Christoph ^a   Engels, Martin ^a   Nee, Jens ^a   Petzinka, Victor ^a   Schröder, Tim ^a   Jörres, Achim ^a   Kruse, Jan ^a   Storm, Christian ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

cardiac arrest; targeted temperature management; volatile sedation

Indexed keywords

ISOFLURANE; NEURON SPECIFIC ENOLASE; REMIFENTANIL; ENOLASE; FENTANYL; HYPNOTIC SEDATIVE AGENT; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; MIDAZOLAM;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; BLEEDING; DISEASE SEVERITY; FEMALE; HEART ARREST; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERCAPNIA; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SEDATION; SURVIVOR; TRACHEOTOMY; VENTILATOR; AGED; ARTIFICIAL VENTILATION; BLOOD; BODY TEMPERATURE; CHEMICALLY INDUCED; DEEP SEDATION; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PROCEDURES; PROPENSITY SCORE; RETROSPECTIVE STUDY; SOMATOSENSORY EVOKED POTENTIAL;

ADMINISTRATION, INHALATION; ADMINISTRATION, INTRAVENOUS; AGED; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; BODY TEMPERATURE; DEEP SEDATION; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; FENTANYL; HEART ARREST; HUMANS; HYPERCAPNIA; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; ISOFLURANE; LENGTH OF STAY; MALE; MIDAZOLAM; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; PROPENSITY SCORE; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES;

EID: 85004190364     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002185     Document Type: Article

References (36)

1. Nolan JP, Soar J, Zideman DA, et al. ERC Guidelines Writing Group: European Resuscitation Council Guidelines for Resuscitation 2010 Section 1. Executive summary. Resuscitation 2010; 81: 1219-1276
2. Samaniego EA, Mlynash M, Caulfield AF, et al. Sedation confounds outcome prediction in cardiac arrest survivors treated with hypothermia. Neurocrit Care 2011; 15: 113-119
3. Martin J, Heymann A, Basell K, et al. Evidence and consensusbased German guidelines for the management of analgesia, sedation and delirium in intensive care-short version. Ger Med Sci 2010; 8: Doc02
4. Willatts SM, Prys-Roberts C, Kong KL, et al. Isoflurane compared with midazolam in the intensive care unit. BMJ 1989; 299: 389
5. Spencer EM, Willatts SM. Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Med 1992; 18: 415-421
6. Sackey PV, Martling CR, Granath F, et al. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med 2004; 32: 2241-2246
7. Tanigami H, Yahagi N, Kumon K, et al. Long-Term sedation with isoflurane in postoperative intensive care in cardiac surgery. Artif Organs 1997; 21: 21-23
8. Bellgardt M, Bomberg H, Herzog-Niescery J, et al. Survival after longterm isoflurane sedation as opposed to intravenous sedation in critically ill surgical patients: Retrospective analysis. Eur J Anaesthesiol 2016; 33: 6-13
9. Hanagata K, Matsukawa T, Sessler DI, et al. Isoflurane and sevoflurane produce a dose-dependent reduction in the shivering threshold in rabbits. Anesth Analg 1995; 81: 581-584
10. Mesnil M, Capdevila X, Bringuier S, et al. Long-Term sedation in intensive care unit: A randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam. Intensive Care Med 2011; 37: 933-941
11. Hellstrom J, Owall A, Martling CR, et al. Inhaled isoflurane sedation during therapeutic hypothermia after cardiac arrest: A case series. Crit Care Med 2014; 42: e161-e166
12. Badjatia N, Strongilis E, Gordon E, et al. Metabolic impact of shivering during therapeutic temperature modulation: The Bedside Shivering Assessment Scale. Stroke 2008; 39: 3242-3247
13. Nolan JP, Soar J, Cariou A, et al. European Resuscitation Council Guidelines for Resuscitation 2015: Section 5. Post resuscitation care. Resuscitation 2015; 95: 202-222
14. C=g therapeutic temperature modulation: The Columbia anti-shivering protocol. Neurocrit Care 2011; 14: 389-394
15. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975; 1: 480-484
16. Leithner C, Storm C, Hasper D, et al. Prognosis for brain function following cardiopulmonary resuscitation and therapeutic hypothermia. Akt Neurol 2012; 39: 145-154
17. Scheel M, Storm C, Gentsch A, et al. The prognostic value of graywhite-matter ratio in cardiac arrest patients treated with hypothermia. Scand J Trauma Resusc Emerg Med 2013; 21: 23
18. Kurth T, Walker AM, Glynn RJ, et al. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 2006; 163: 262-270
19. Leslie K, Sessler DI, Bjorksten AR, et al. Mild hypothermia alters propofol pharmacokinetics and increases the duration of action of atracurium. Anesth Analg 1995; 80: 1007-1014
20. Sackey PV, Martling CR, Carlsward C, et al. Short- And long-Term follow-up of intensive care unit patients after sedation with isoflurane and midazolam-A pilot study. Crit Care Med 2008; 36: 801-806
21. Li L, Zuo Z. Isoflurane postconditioning induces neuroprotection via Akt activation and attenuation of increased mitochondrial membrane permeability. Neuroscience 2011; 199: 44-50
22. Kapinya KJ, Lowl D, Futterer C, et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002; 33: 1889-1898
23. Olsen KS, Henriksen L, Owen-Falkenberg A, et al. Effect of 1 or 2 MAC isoflurane with or without ketanserin on cerebral blood flow autoregulation in man. Br J Anaesth 1994; 72: 66-71
24. Li CX, Patel S, Wang DJ, et al. Effect of high dose isoflurane on cerebral blood flow in macaque monkeys. Magn Reson Imaging 2014; 32: 956-960
25. Tobias JD. Inhalational anesthesia: Basic pharmacology, end organ effects, and applications in the treatment of status asthmaticus. J Intensive Care Med 2009; 24: 361-371
26. Chaillan M, Badin J, Kerforne T, et al: [Severe acute asthma: Isoflurane administration via AnaConDa', is it safe?]. Ann Fr Anesth Reanim 2011; 30: 70-72
27. Sturesson LW, Bodelsson M, Jonson B, et al. Anaesthetic conserving device AnaConDa: Dead space effect and significance for lung protective ventilation. Br J Anaesth 2014; 113: 508-514
28. Sturesson LW, Malmkvist G, Bodelsson M, et al. Carbon dioxide rebreathing with the anaesthetic conserving device, AnaConDaR. Br J Anaesth 2012; 109: 279-283
29. Bosel J, Purrucker JC, Nowak F, et al. Volatile isoflurane sedation in cerebrovascular intensive care patients using AnaConDa(R): Effects on cerebral oxygenation, circulation, and pressure. Intensive Care Med 2012; 38: 1955-1964
30. Purrucker JC, Renzland J, Uhlmann L, et al. Volatile sedation with sevoflurane in intensive care patients with acute stroke or subarachnoid haemorrhage using AnaConDaR: An observational study. Br J Anaesth 2015; 114: 934-943
31. Nordmark J, Rubertsson S, Mortberg E, et al. Intracerebral monitoring in comatose patients treated with hypothermia after a cardiac arrest. Acta Anaesthesiol Scand 2009; 53: 289-298
32. Naito H, Isotani E, Callaway CW, et al. Intracranial pressure increases during rewarming period after mild therapeutic hypothermia in postcardiac arrest patients. Ther Hypothermia Temp Manag 2016 May 23. [Epub ahead of print]
33. Iida K, Satoh H, Arita K, et al. Delayed hyperemia causing intracranial hypertension after cardiopulmonary resuscitation. Crit Care Med 1997; 25: 971-976
34. Inamasu J, Miyatake S, Suzuki M, et al. Early CT signs in out-of-hospital cardiac arrest survivors: Temporal profile and prognostic significance. Resuscitation 2010; 81: 534-538
35. Rosenberg H, Davis M, James D, et al. Malignant hyperthermia. Orphanet J Rare Dis 2007; 2: 21
36. Nielsen N, Wetterslev J, Cronberg T, et al. TTM Trial Investigators: Targeted temperature management at 33'C versus 36'C after cardiac arrest. N Engl J Med 2013; 369: 2197-2206